End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 CNY | -5.08% | +2.28% | +4.40% |
Apr. 15 | Sinoma Science & Technology Co.,Ltd. Approves Cash Dividend for the Year 2023 | CI |
Mar. 22 | Sinoma Science & Technology Co.,Ltd. Proposes Final Cash Dividend for 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- With a P/E ratio at 11.2 for the current year and 8.05 for next year, earnings multiples are highly attractive compared with competitors.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.40% | 4.06B | C | ||
+13.11% | 5.28B | C | ||
-9.05% | 4.65B | C- | ||
-8.15% | 1.92B | - | - | |
-4.59% | 1.47B | B+ | ||
-11.67% | 1.27B | B | ||
-5.68% | 944M | - | ||
-20.36% | 751M | - | D+ | |
-4.64% | 608M | - | - | |
-31.40% | 417M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 002080 Stock
- Ratings Sinoma Science & Technology Co.,Ltd.